Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Thursday, April 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Shareholder Class Action

CHICAGO — Directors are selling Sagent Pharmaceuticals too cheaply through an unfair process to Nichi-Iko Pharmaceutical, for $21.75 a share or $714 million, shareholders claim in Federal Court.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...